Education
About Us
Working with TipRanks
Follow Us
Christina Rossi Insider Profile
4 Followers
Christina Rossi, COO at Blueprint Medicines, holds 71.54K shares in Blueprint Medicines (Ticker: BPMC), holds ― shares in Xilio Therapeutics (Ticker: XLO). Most recently, Christina Rossi Sold ― shares of Blueprint Medicines on Mar 07, 2025 for an estimated value of 576.76K.
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christina Rossi holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 05, 2021 - Mar 05, 2022
Return:+40.50%
The most profitable trade made by Christina Rossi
Christina Rossi's Trading History
Blueprint Medicines
Mar 07, 2025
COO
Informative Sell
576.76K
$6.23M
Xilio Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Christina Rossi's performance on stock
You May Also Like
Christina Rossi insider profile FAQ
What is the percentage of profitable transactions made by Christina Rossi?
The percentage of profitable transactions made by Christina Rossi is 38%.
What is the average return per transaction made by Christina Rossi?
The average return per transaction made by Christina Rossi is -23.60%.
What stocks does Christina Rossi hold?
Christina Rossi holds: BPMC, XLO stocks.
What was Christina Rossi’s latest transaction?
Christina Rossi latest transaction was an Informative Sell of $576.76K.
What was Christina Rossi's most profitable transaction?
Christina Rossi’s most profitable transaction was an Informative Sell of BPMC stock on March 5, 2021. The return on the trade was 40.50%.
What is Christina Rossi's role in Blueprint Medicines?
Christina Rossi's role in Blueprint Medicines is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.